Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1488.31% is 234% below its 5-year average of -445.33%, around the middle of its 5-year range (-3671.26%–0.00%).
6.50% above its 12-month average of -1591.75%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -752.11%.
OPERATING MARGIN
-1488.31%
OPERATING MARGIN AVG TTM
-1591.75%
OPERATING MARGIN AVG 3Y
-1263.60%
OPERATING MARGIN AVG 5Y
-445.33%
OPERATING MARGIN AVG 10Y
-3.24%
OPERATING MARGIN AVG 15Y
1.12%
OPERATING MARGIN AVG 20Y
-0.18%
CURRENT VS TTM AVG
+6.50%
CURRENT VS 3Y AVG
-17.78%
CURRENT VS 5Y AVG
-234.20%
CURRENT VS 10Y AVG
-45776.71%
CURRENT VS 15Y AVG
-132552.32%
CURRENT VS 20Y AVG
-837461.74%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
CAMP4 Therapeutics Corporation
Market Cap
$251.64M
Operating Margin
-1488.31%
TTM Avg
-1591.75%
3Y Avg
-1263.60%
5Y Avg
-445.33%
Market Cap
$248.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$247.45M
Operating Margin
-164525.50%
TTM Avg
-98218.45%
3Y Avg
-66780.63%
5Y Avg
-44520.42%
Market Cap
$247.23M
Operating Margin
-103.99%
TTM Avg
-400.39%
3Y Avg
-200.20%
5Y Avg
-133.47%
Market Cap
$245.65M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$244.25M
Operating Margin
9.95%
TTM Avg
-10.78%
3Y Avg
-18.24%
5Y Avg
-54.36%
Market Cap
$259.30M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$239.89M
Operating Margin
0.56%
TTM Avg
-0.74%
3Y Avg
-7.55%
5Y Avg
-6.74%
Market Cap
$239.45M
Operating Margin
-1026.28%
TTM Avg
-515.73%
3Y Avg
-257.87%
5Y Avg
-257.87%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CAMP4 Therapeutics Corporation (CAMP) | $251.64M | -1488.31% | -1591.75% | -1263.60% | -445.33% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $248.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| InflaRx N.V. (IFRX)vs › | $247.45M | -164525.50% | -98218.45% | -66780.63% | -44520.42% |
| Invivyd, Inc. (IVVD)vs › | $247.23M | -103.99% | -400.39% | -200.20% | -133.47% |
| Galectin Therapeutics Inc. (GALT)vs › | $245.65M | 0.00% | 0.00% | 0.00% | 0.00% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $244.25M | 9.95% | -10.78% | -18.24% | -54.36% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| High Tide Inc. (HITI)vs › | $239.89M | 0.56% | -0.74% | -7.55% | -6.74% |
| BioAge Labs Inc. (BIOA)vs › | $239.45M | -1026.28% | -515.73% | -257.87% | -257.87% |
| Anika Therapeutics, Inc. (ANIK)vs › | $264.05M | -4.24% | -7.03% | -2.53% | -5.01% |
Gross Margin
53.1%
Operating Margin
-1488.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -752.11% |
| 2026-03-31 | -1010.12% |
| 2025-12-31 | -3671.26% |
| 2025-09-30 | -1654.97% |
| 2025-06-30 | -870.27% |
| 2025-03-31 | -1526.81% |
| 2024-12-31 | -2152.45% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-08-31 | -3525.14% |
| 2023-05-31 | -3.36% |
| 2023-02-28 | -2.01% |
| 2022-11-30 | -4.88% |
| 2022-08-31 | -7.33% |
| 2022-05-31 | -14.42% |
| 2022-02-28 | -6.46% |
| 2021-11-30 | -9.54% |
| 2021-08-31 | -1.26% |
| 2021-05-31 | -1.54% |
| 2021-02-28 | -0.35% |
| 2020-11-30 | -22.74% |
| 2020-08-31 | -7.48% |
| 2020-05-31 | -12.36% |
| 2020-02-29 | -28.61% |
| 2019-11-30 | -4.14% |
| 2019-08-31 | -4.94% |
| 2019-05-31 | -7.46% |
| 2019-02-28 | 18.28% |
| 2018-11-30 | 0.68% |
| 2018-08-31 | 4.42% |
| 2018-05-31 | -0.60% |
| 2018-02-28 | 2.06% |
| 2017-11-30 | 4.49% |
| 2017-08-31 | 3.49% |
| 2017-05-31 | -1.51% |
| 2017-02-28 | -2.69% |
| 2016-11-30 | 2.15% |
| 2016-08-31 | 4.32% |
| 2016-05-31 | -2.24% |
| 2016-02-29 | 6.40% |
| 2015-11-30 | 11.53% |
| 2015-08-31 | 11.31% |
| 2015-05-31 | 10.77% |
| 2015-02-28 | 12.79% |
| 2014-11-30 | 10.21% |
| 2014-08-31 | 8.50% |
| 2014-05-31 | 7.81% |
| 2014-02-28 | 7.81% |
| 2013-11-30 | 9.50% |
| 2013-08-31 | 8.09% |
| 2013-05-31 | 5.35% |
| 2013-02-28 | 7.46% |
| 2012-11-30 | 9.72% |
| 2012-08-31 | 8.59% |
| 2012-05-31 | 9.76% |
| 2012-02-28 | 4.34% |
| 2011-11-26 | 5.80% |
| 2011-08-27 | 8.74% |
| 2011-05-28 | 2.56% |
| 2011-02-28 | 1.53% |
| 2010-11-27 | 0.46% |
| 2010-08-28 | -1.91% |
| 2010-05-29 | -7.88% |
| 2010-02-28 | -2.84% |
| 2009-11-28 | -7.95% |
| 2009-08-29 | -12.84% |
| 2009-05-30 | -15.17% |
| 2009-02-28 | -188.74% |
| 2008-11-29 | -9.46% |
| 2008-08-30 | -7.79% |
| 2008-05-31 | -1.69% |
| 2008-03-01 | -38.62% |
| 2007-12-01 | -209.66% |
| 2007-09-01 | -14.90% |
| 2007-06-02 | -37.78% |
| 2007-03-03 | 0.82% |
| 2006-11-30 | 2.38% |
| 2006-08-31 | 4.18% |
| 2006-05-31 | -71.95% |
| 2006-02-28 | 11.79% |
| 2005-11-30 | 4.16% |
| 2005-08-31 | 10.57% |
| 2005-05-31 | 6.89% |
| 2005-02-28 | 7.53% |
| 2004-11-30 | 5.02% |
| 2004-08-31 | 5.67% |
| 2004-05-31 | 4.99% |
| 2004-02-28 | 7.18% |
| 2003-11-30 | 8.69% |
| 2003-08-31 | 2.26% |
| 2003-05-31 | -7.51% |
| 2003-03-01 | 5.35% |
| 2002-11-30 | 6.74% |
| 2002-08-31 | 10.30% |
